Senior Computational Geneticist

• United States
  - Massachusetts
  - Cambridge

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

To fully realize Pfizer’s purpose – Breakthroughs that change patients’ lives – we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

Pfizer Research & Development serves as the beating heart of Pfizer's trailblazing product pipeline, the essence of our mission to bring life-changing medicines to the world.

Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

Human genetics has established itself as a cornerstone of modern drug discovery, yet we are only beginning to unlock the full potential of the rich biomedical data now being generated.

We are seeking a geneticist with a passion for applying cutting‑edge approaches, including genetic epidemiology, quantitative genetics, computational biology, functional omics, machine learning and artificial intelligence, and other multi‑omics data resources, to accelerate the identification of causal mechanisms, therapeutic indications, biomarkers, and patient stratification strategies.

The Integrative Biology team within the Internal Medicine Research Unit works closely with disease area biologists to address unmet medical needs in metabolic diseases, including obesity and cardiovascular disease, with a particular focus on atherosclerotic cardiovascular disease. We do this by developing and applying advanced methods to analyze human genetics and other large‑scale molecular datasets.

A critical component of this role will be working in close partnership with our AI for Internal Medicine (AIM2) discovery centre . You will act as a key scientific collaborator, helping to guide the development of AI/ML tools by providing domain‑specific genetic expertise, and translating AI‑generated insights into actionable therapeutic hypotheses for disease area project teams.

The ideal candidate for this role will also work with our external partners and collaborators to help manage external collaborations, ensure the timely delivery of high‑quality genetics and genomics data, and to incorporate results into target identification and validation.

The applied human genetics scientist position offers an opportunity to execute science‑based drug discovery within one of the world’s leading developers of human therapeutics, at Pfizer’s Kendall Square research facility in Cambridge Massachusetts.

• Provide quantitative genetics expertise and conduct analyses to derive impactful results through interactions with biologists within the Internal Medicine Research Unit.
• Provide expertise and quantitative skills on the application of genetics and functional genomics to inform project teams in:
  • Identification of novel therapeutic targets
  • Review and validation of therapeutic hypotheses
  • Mechanistic understanding of disease pathogenesis and causal pathways
  • Innovative approaches to identifying mechanism‑related biomarkers via integrating genetics with clinical and ‘omic datasets.
  • Identification of potential disease indications.
  • Matching novel therapies to patients with relevant disease sub‑types.
• Ensure high‑quality genetic and ‘omics data is incorporated into exploratory research by interacting with internal partners in statistics, bioinformatics, computational biology, clinicians, and project leaders to drive genetic data analysis, data integration, and genetic methodology.
• Partner closely with AIM2 scientists and our partners in machine learning and AI to identify opportunities where AI‑enabled approaches can enhance genetics‑driven target discovery, causal inference, biological interpretation, biomarker identification, and patient stratification.
• Work in collaboration with research biologists and project teams to identify the best opportunities to translate genetic and related data to inform and prioritise assets in the portfolio; and with clinical teams to inform optimum patient selection, stratification and trial design.
• Critically evaluate and incorporate…